Testosterone replacement therapy is rising in popularity. What is it?
Read more at CBS News
-
Testosterone replacement therapy surges in popularity among men and women
Prescriptions for testosterone have jumped from 7.3 million in 2019 to over 11 million in 2024. CBS News chief medical correspondent Dr. Jon LaPook explains what's driving the rise and who is ...CBS News - 6h -
Redrafting 2023 NBA Draft: How lottery would look knowing what we know now as Amen Thompson rises, Scoot slips
These are the picks teams wish they made nearly two years agoCBS Sports - 1d -
Blind children given sight after experimental gene therapy
Four toddlers born with a rare eye condition have seen "life-changing improvements", say UK doctors.BBC News - 4d -
‘Photography is therapy for me’: Martin Parr on humour, holidaying and life behind the lens
He has a prolific career and extensive portfolio, with his images of British life especially iconic. At 72, he tells Miranda Sawyer, he’s still thinking about what to shoot next. About 20 years ...The Guardian - 2d -
Ranking the New M.L.S. Kits, From the Most Popular to the Most Disorienting
The next season of Major League Soccer is here, and so is a new batch of uniforms for every team.The New York Times - 3d -
ETFs that allow investors to make big bets on market moves are gaining in popularity
Leveraged ETFs amplify the daily returns of an index or stock using financial derivatives.CNBC - 1d -
Ahmed replaces Carse in England's Champions Trophy squad
England bowler Brydon Carse is ruled out of the remainder of the Champions Trophy and will be replaced by leg-spinner Rehan Ahmed.BBC News - 1d -
Fed Flags Rising Inflation Risks and Rising Uncertainty About Trump’s Policies
Rates cuts are still on the menu, but like many businesses, Fed officials are having a tough time judging the impact of Trump’s tariff and immigration plans.Inc. - 4d -
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.CNBC - 4d
More from CBS News
-
Mortgage rates stay under 7%. Should you buy a home now?
Today's mortgage rates are higher than they were a few years ago, but it could still be smart to buy a home now.CBS News - 25m -
21 DOGE staffers, whose employment predated Musk agency, resign
The officials wrote in a letter that they "will not lend our expertise to carry out or legitimize DOGE's actions."CBS News - 32m -
This is who the White House says is the DOGE acting administrator
The White House finally gave a name for the DOGE acting administrator.CBS News - 42m -
How to grow your home equity in 2025
Thinking of borrowing from your home equity this year? Here are three effective ways to grow it first.CBS News - 42m -
Georgia deputy who killed exonerated Florida man won't be charged
Leonard Cure, 53, was killed by a Georgia sheriff's deputy just three years after Florida authorities had freed him from prison.CBS News - 46m
More in Top stories
-
Ukraine Agrees to U.S. Deal for Mineral Rights
President Trump had insisted he wanted “payback” for past aid, shifting America’s three-year alliance with Ukraine to a mercantile footing.The New York Times - 12m -
Residents could be out of their homes 'for a year'
Godstone residents affected by the sinkholes attend a meeting to discuss what happens next.BBC News - 16m -
Some Republicans Sharply Criticize Trump’s Embrace of Russia at the U.N.
Their pointed remarks followed votes on Monday in which the United States broke with allies to side with Russia over the war in Ukraine.The New York Times - 17m -
Israel says it is conducting strikes in southern Syria
Israel confirmed it is conducting strikes in southern Syria, as the new Syrian government calls for the full withdrawal of Israeli forces from Syrian territory.ABC News - 18m -
Couple's trauma after body placed next to them on flight
Cabin crew placed the body of a passenger who died mid-flight in an empty seat beside the pair.BBC News - 19m